Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Autolus Therapeutics plc ADR (NASDAQ: AUTL) closed at $2.32 in the last session, up 2.20% from day before closing price of $2.27. In other words, the price has increased by $2.20 from its previous closing price. On the day, 1.71 million shares were traded.
Ratios:
We take a closer look at AUTL’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.99 and its Current Ratio is at 9.21. In the meantime, Its Debt-to-Equity ratio is 0.84 whereas as Long-Term Debt/Eq ratio is at 0.83.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on November 18, 2024, Upgraded its rating to Buy and sets its target price to $7.60 from $7 previously.
On November 15, 2024, Redburn Atlantic Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $13.
On November 09, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $10.Deutsche Bank initiated its Buy rating on November 09, 2023, with a $10 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 16 ’24 when Martin Pule bought 698,741 shares for $4.23 per share.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 68.53 while its Price-to-Book (P/B) ratio in mrq is 1.66.
Stock Price History:
Over the past 52 weeks, AUTL has reached a high of $5.00, while it has fallen to a 52-week low of $1.11. The 50-Day Moving Average of the stock is 38.76%, while the 200-Day Moving Average is calculated to be -6.94%.
Shares Statistics:
A total of 266.14M shares are outstanding, with a floating share count of 240.33M. Insiders hold about 9.70% of the company’s shares, while institutions hold 54.13% stake in the company.
